Company Mega Pharma Europe S.r.l. with Fiscal Code 38576915
recorded a turnover of 2024 of
- ,
with a net profit of
-4.431
and having an average number of employees of
- .
The company operates in the field of Fabricarea preparatelor farmaceutice having the NACE code 2120.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Mega Pharma Europe S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
-
-
3.161
0
0
0
0
0
Total Income - EUR
-
-
-
-
5.695
1.868
0
0
0
0
Total Expenses - EUR
-
-
-
-
21.580
11.521
8.510
4.480
3.958
4.431
Gross Profit/Loss - EUR
-
-
-
-
-15.885
-9.654
-8.510
-4.480
-3.958
-4.431
Net Profit/Loss - EUR
-
-
-
-
-15.917
-9.672
-8.510
-4.480
-3.958
-4.431
Employees
-
-
-
-
1
1
1
1
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Check the financial reports for the company - Mega Pharma Europe S.r.l.
Financial Rating - MEGA PHARMA EUROPE S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Mega Pharma Europe S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Mega Pharma Europe S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Mega Pharma Europe S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Mega Pharma Europe S.r.l. - CUI 38576915
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
-
-
23.865
23.107
19.747
18.191
16.636
15.052
Current Assets
-
-
-
-
17.921
30.433
21.704
23.806
23.421
22.413
Inventories
-
-
-
-
12.745
12.503
13.748
17.613
17.560
16.683
Receivables
-
-
-
-
4.924
5.567
5.456
5.473
5.631
5.213
Cash
-
-
-
-
252
12.363
2.500
719
230
516
Shareholders Funds
-
-
-
-
-27.410
-36.562
-44.261
-48.879
-52.689
-56.825
Social Capital
-
-
-
-
211
207
202
203
202
201
Debts
-
-
-
-
69.196
90.102
85.712
90.876
92.746
94.290
Income in Advance
-
-
-
-
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"2120 - 2120"
CAEN Financial Year
2120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
22.413 euro in 2024 which includes Inventories of
16.683 euro, Receivables of
5.213 euro and cash availability of
516 euro.
The company's Equity was valued at
-56.825 euro, while total Liabilities amounted to
94.290 euro.
Equity decreased by -4.431 euro, from -52.689 euro in 2023, to -56.825 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Mega Pharma Europe S.r.l.